NCT06211348View on ClinicalTrials.gov

Genomic Sequencing in Anatomically Normal Fetuses

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2030

Conditions
Pregnant Individuals Requesting Standard Microarray
Interventions
DEVICE

Genomic Sequencing

Individuals who request prenatal diagnostic testing with standard chromosomal microarray will be offered genomic sequencing (GS) as an option to assess for additional disease risk.

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER